Oncolys BioPharma Inc.
TSE:4588.T
905 (JPY) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | 2013 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 31.384 | 0 | 0 | 0 | 28.038 | 35 | 191.673 | 358.357 | 233.027 | 193.125 | 324.177 | 125.25 | 130.464 | 62.603 | 106.568 | 71.496 | 65.841 | 70.274 | 663.733 | 19.105 | 572.623 | 48.383 | 50.127 | 27.977 | 56.571 | 33.874 | 200.112 | 9.123 | 4.524 | 15.38 | 131.773 | 1.86 | 15.12 | 29.56 | 101.368 | 12.026 | 5.763 | 2.146 | 21.671 | 2.923 | 1.863 | 2.34 | 1.14 |
| Cost of Revenue
| 0 | 0 | 1.606 | 0.539 | 0.141 | 32.433 | 163.338 | 287.66 | 121.056 | 65.641 | 294.754 | 95.42 | 18.089 | 35.427 | 3.756 | 39.648 | 15.155 | 19.506 | 53.789 | 8.277 | 9.299 | 41.535 | 31.9 | 19.422 | 41.486 | 28.523 | 67.589 | 3.961 | 0.007 | 0 | 0.008 | 0 | 0 | 0.008 | 0 | 0.001 | 0.003 | 0.013 | 0.329 | 0.021 | 0.006 | 0.038 | 0.029 |
| Gross Profit
| 31.384 | 0 | -1.606 | -0.539 | 27.897 | 2.567 | 28.335 | 70.697 | 111.971 | 127.484 | 29.423 | 29.83 | 112.375 | 27.176 | 102.812 | 31.848 | 50.686 | 50.768 | 609.944 | 10.828 | 563.324 | 6.848 | 18.227 | 8.555 | 15.085 | 5.351 | 132.523 | 5.162 | 4.517 | 15.38 | 131.765 | 1.86 | 15.12 | 29.552 | 101.368 | 12.025 | 5.76 | 2.133 | 21.342 | 2.902 | 1.857 | 2.302 | 1.111 |
| Gross Profit Ratio
| 1 | 0 | 0 | 0 | 0.995 | 0.073 | 0.148 | 0.197 | 0.481 | 0.66 | 0.091 | 0.238 | 0.861 | 0.434 | 0.965 | 0.445 | 0.77 | 0.722 | 0.919 | 0.567 | 0.984 | 0.142 | 0.364 | 0.306 | 0.267 | 0.158 | 0.662 | 0.566 | 0.998 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.999 | 0.994 | 0.985 | 0.993 | 0.997 | 0.984 | 0.975 |
| Reseach & Development Expenses
| 301.833 | 222.142 | 454.603 | 260.385 | 457.795 | 179.157 | 160.411 | 201.815 | 237.431 | 347.834 | 334.109 | 170.071 | 214.666 | 106.628 | 340.212 | 647.03 | 0 | 0 | 153.509 | 409.185 | 0 | 0 | 195.749 | 410.072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 144.05 | 156.73 | 162.739 | 149.125 | 145.513 | 148.988 | 135.049 | 147.365 | 148.691 | 164.397 | 186.219 | 189.808 | 181.855 | 270.001 | 617.516 | 539.35 | 429.341 | 338.458 | 576.526 | 322.595 | 473.963 | 371.43 | 350.382 | 280.241 | 356.143 | 308.015 | 442.495 | 263.916 | 279.064 | 250.495 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| -144.05 | 0 | 0 | 2.759 | 0 | 328.145 | 295.46 | 349.18 | 386.122 | 512.231 | -40 | -0.887 | -12.912 | -14.168 | -17.2 | -0.287 | -6.055 | -0.03 | -32.103 | -9.865 | 0.027 | 0.05 | 350.382 | 280.241 | 356.143 | 0.03 | 442.495 | 263.916 | 279.064 | 0.029 | -0.798 | 0.81 | 0.266 | 0.025 | -0.373 | 205.424 | 0.511 | 98.87 | 10.458 | 0.493 | 19.105 | 67.994 | 2.187 |
| Operating Expenses
| 445.883 | 378.872 | 617.342 | 410.049 | 603.449 | 328.145 | 295.46 | 349.18 | 386.122 | 512.231 | 520.328 | 359.879 | 396.521 | 376.629 | 609.959 | 539.063 | 423.286 | 338.458 | 534.418 | 322.595 | 473.963 | 371.43 | 350.382 | 280.241 | 356.143 | 308.015 | 442.495 | 263.916 | 279.064 | 250.495 | 313.519 | 270.82 | 243.655 | 211.614 | 354.171 | 205.424 | 206.928 | 306.339 | 325.867 | 167.832 | 191.551 | 170.898 | 258.789 |
| Operating Income
| -414.499 | -378.872 | -618.948 | -410.049 | -575.411 | -325.578 | -267.125 | -278.483 | -274.151 | -384.748 | -490.905 | -330.05 | -284.146 | -349.453 | -507.148 | -507.214 | -372.6 | -287.69 | 75.525 | -311.767 | 89.361 | -364.582 | -332.155 | -271.686 | -341.058 | -302.664 | -309.973 | -258.754 | -274.547 | -235.115 | -181.755 | -268.96 | -228.535 | -182.061 | -252.803 | -193.398 | -201.168 | -304.206 | -304.524 | -164.929 | -189.694 | -168.597 | -257.678 |
| Operating Income Ratio
| -13.207 | 0 | 0 | 0 | -20.523 | -9.302 | -1.394 | -0.777 | -1.176 | -1.992 | -1.514 | -2.635 | -2.178 | -5.582 | -4.759 | -7.094 | -5.659 | -4.094 | 0.114 | -16.319 | 0.156 | -7.535 | -6.626 | -9.711 | -6.029 | -8.935 | -1.549 | -28.363 | -60.687 | -15.287 | -1.379 | -144.602 | -15.115 | -6.159 | -2.494 | -16.082 | -34.907 | -141.755 | -14.052 | -56.425 | -101.822 | -72.05 | -226.033 |
| Total Other Income Expenses Net
| 24.794 | 15.58 | -45.981 | 6.705 | 31.061 | 2.623 | -45.831 | 14.542 | 33.265 | 56.526 | -143.918 | 2.174 | -15.244 | -0.172 | -41.592 | -372.514 | -5.231 | 2.631 | -396.314 | -4.408 | -1.771 | 5.363 | 1.2 | 12.53 | 11.503 | -7.774 | -0.431 | -0.99 | -0.912 | -6.463 | -16.695 | -43.965 | -2.89 | -3.483 | -2.734 | -0.506 | -0.02 | 100.135 | 11.975 | 5.759 | 9.101 | 63.804 | -35.426 |
| Income Before Tax
| -389.705 | -363.292 | -664.929 | -403.344 | -544.35 | -322.955 | -312.956 | -263.941 | -240.886 | -328.222 | -634.823 | -327.876 | -299.389 | -349.626 | -548.74 | -879.728 | -377.832 | -285.059 | -320.788 | -316.176 | 87.591 | -359.22 | -330.955 | -259.156 | -329.555 | -310.439 | -310.403 | -259.744 | -275.46 | -241.578 | -198.449 | -312.925 | -231.425 | -185.545 | -255.537 | -193.905 | -201.187 | -204.072 | -292.549 | -159.171 | -180.593 | -104.793 | -293.104 |
| Income Before Tax Ratio
| -12.417 | 0 | 0 | 0 | -19.415 | -9.227 | -1.633 | -0.737 | -1.034 | -1.7 | -1.958 | -2.618 | -2.295 | -5.585 | -5.149 | -12.305 | -5.739 | -4.056 | -0.483 | -16.549 | 0.153 | -7.425 | -6.602 | -9.263 | -5.826 | -9.165 | -1.551 | -28.471 | -60.889 | -15.707 | -1.506 | -168.239 | -15.306 | -6.277 | -2.521 | -16.124 | -34.91 | -95.094 | -13.5 | -54.455 | -96.937 | -44.783 | -257.109 |
| Income Tax Expense
| 0.931 | 0.94 | 0.733 | 0.736 | 0.721 | 0.736 | 0.733 | 0.738 | 0.723 | 0.738 | 0.938 | 0.943 | 0.903 | 0.941 | 0.938 | 0.946 | 0.881 | 0.962 | 0.939 | 0.965 | 0.883 | 0.965 | 0.939 | 0.973 | 0.882 | 0.946 | 0.94 | 0.955 | 0.654 | 0.969 | 1.398 | 0.655 | 0.317 | 0.682 | 0.629 | 0.722 | 0.636 | 0.601 | -0.432 | 1.045 | 0.622 | 0.657 | 0.821 |
| Net Income
| -390.635 | -364.233 | -665.662 | -404.081 | -545.071 | -323.691 | -313.689 | -264.679 | -241.609 | -328.96 | -635.76 | -328.819 | -300.293 | -350.567 | -549.679 | -880.674 | -378.712 | -286.022 | -321.727 | -317.141 | 86.707 | -360.185 | -331.895 | -260.129 | -330.436 | -311.386 | -311.342 | -260.699 | -276.115 | -242.547 | -199.847 | -313.581 | -231.741 | -186.228 | -256.166 | -194.628 | -201.822 | -204.674 | -292.118 | -160.216 | -181.215 | -105.45 | -293.925 |
| Net Income Ratio
| -12.447 | 0 | 0 | 0 | -19.44 | -9.248 | -1.637 | -0.739 | -1.037 | -1.703 | -1.961 | -2.625 | -2.302 | -5.6 | -5.158 | -12.318 | -5.752 | -4.07 | -0.485 | -16.6 | 0.151 | -7.444 | -6.621 | -9.298 | -5.841 | -9.192 | -1.556 | -28.576 | -61.033 | -15.77 | -1.517 | -168.592 | -15.327 | -6.3 | -2.527 | -16.184 | -35.02 | -95.375 | -13.48 | -54.812 | -97.271 | -45.064 | -257.829 |
| EPS
| -18.73 | -18.24 | -35.09 | -23.02 | -31.47 | -18.69 | -18.11 | -2.46 | -2.25 | -18.98 | -6.04 | -20.97 | -19.15 | -22.36 | -35.06 | -56.17 | -26.48 | -19.96 | -22.64 | -22.31 | 6.48 | -26.91 | -25.36 | -23.46 | -29.81 | -28.09 | -28.25 | -27.85 | -29.49 | -25.91 | -21.66 | -34.15 | -25.23 | -20.28 | -27.89 | -21.19 | -21.98 | -22.29 | -31.81 | -17.51 | -19.81 | -11.53 | -32.13 |
| EPS Diluted
| -18.73 | -18.24 | -35.09 | -23.02 | -31.47 | -18.69 | -18.11 | -2.46 | -2.25 | -18.98 | -5.91 | -20.97 | -19.15 | -22.36 | -35.06 | -56.17 | -26.43 | -19.96 | -22.45 | -22.13 | 6.48 | -26.91 | -24.79 | -19.43 | -29.81 | -28.09 | -28.08 | -23.52 | -29.49 | -25.91 | -21.35 | -33.49 | -25.23 | -20.28 | -27.89 | -21.19 | -21.98 | -22.29 | -31.81 | -17.45 | -19.81 | -11.53 | -32.13 |
| EBITDA
| -414.499 | -378.872 | -617.342 | -402.346 | -543.424 | -322.236 | -307.621 | -262.865 | -239.813 | -348.764 | -633.845 | -326.794 | -298.212 | -348.694 | -536.563 | -878.596 | -376.607 | -284.283 | -319.662 | -315.125 | 88.772 | -358.631 | -330.317 | -258.477 | -328.837 | -309.677 | -309.583 | -258.886 | -274.559 | -240.883 | -171.88 | -269.014 | -230.591 | -184.677 | -254.609 | -192.925 | -200.178 | -202.745 | -288.487 | -157.929 | -179.652 | -103.41 | -292.176 |
| EBITDA Ratio
| -13.207 | 0 | 0 | 0 | -19.382 | -9.207 | -1.605 | -0.734 | -1.029 | -1.806 | -1.955 | -2.609 | -2.286 | -5.57 | -5.035 | -12.289 | -5.72 | -4.045 | -0.482 | -16.494 | 0.155 | -7.412 | -6.59 | -9.239 | -5.813 | -9.142 | -1.547 | -28.377 | -60.689 | -15.662 | -1.304 | -144.631 | -15.251 | -6.248 | -2.512 | -16.042 | -34.735 | -94.476 | -13.312 | -54.03 | -96.432 | -44.192 | -256.295 |